
Antidepressant Withdrawal, Online Data, and a Bottom Line
How many people who take an antidepressant truly have severe difficulties when they try to taper off? Or, is it “all in their mind”?
A recent
Surprisingly, this has not been directly studied (per an hour’s negative search on PUB MED, consistent with work by a UCLA
For further insight, we can look at online communities referenced in the
Testimonials are easy to dismiss. But regardless of your opinion of testimonials as evidence, the posts at
Other reasons
We have other reasons to avoid venlafaxine. Unlike SRIs, it can raise blood pressure, worsening hypertension, an all-too-common comorbidity with depression. Venlafaxine has also been found
Paroxetine causes significantly more
Citalopram can cause arrhythmias in patients with long QT syndrome11 so rather than putting patients through the hassle of serial electrocardiograms, skip over that one too.
Alternative antidepressants
This leaves fluoxetine, sertraline-and bupropion. According to a meta-analysis I
As published
Conclusion
Before starting any antidepressant, share with the patient the potential for difficult withdrawal when stopping it. This is tricky-because we don’t know how often people have horrendous experiences that are truly a result of the discontinuation. The folks at
References:
1. Carey B. Gebeloff R. Many People Taking Antidepressants Discover They Cannot Quit. The New York Times. April 7, 2018.
2. Witt-Doering J, Shorter D, Kosten T.
3. Cohen D, quoted in Rahhal N. Tens of millions of Americans are struggling to get off antidepressants-and going to extreme lengths to quit. Daily Mail.com, April 9 2018.
4. Ostrow L, Jessell L, Hurd M, et al. Discontinuing Psychiatric Medications: A Survey of Long-Term Users. Psychiatr Serv. 2017;68:1232-1238.
5. Cartwright C, Gibson K, Read J, et al. Long-term antidepressant use: patient perspectives of benefits and adverse effects. Patient Prefer Adherence. 2016;10:1401-1407.
6. US National Library of Medicine. ClinicalTrials.gov. Tapering Off Antidepressants.
7. US National Library of Medicine. ClinicalTrials.gov. Discontinuation of Antidepressant Medication in Primary Care.
8. Post RM, Altshuler LL, Leverich GS, et al. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry. 2006;189:124-131.
9. Serretti A, Mandelli L. Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry. 2010;71:1259-1272.
10. Abbe A, Falissard B. Stopping Antidepressants and Anxiolytics as Major Concerns Reported in Online Health Communities: A Text Mining Approach. JMIR Ment Health. 2017;4:e48.
11. Wang M, Szepietowska B, Polonsky B, et al. Risk of Cardiac Events Associated With Antidepressant Therapy in Patients With Long QT Syndrome. Am J Cardiol. 2018;121:182-187.
12. Phelps J. Is Bupropion Your No. 1 Antidepressant Choice? Psychiatric Times. June 6, 2016.
13. Berigan TR, Harazin JS. Bupropion-Associated Withdrawal Symptoms: A Case Report. Prim Care Companion. J Clin Psychiatry. 1999;1:50–51.
14. Berigan TR. Bupropion-Associated Withdrawal Symptoms Revisited: A Case Report. Prim Care Companion J Clin Psychiatry. 2002;4:78.
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.